Mitigating Neural Hypoexcitability and Weakness During Disuse in Women
Kansas State University · with National Institute of General Medical Sciences (NIGMS) · NCT07166198
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40–65 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 20
- US sites recruiting
- 1
- Study start
- May 1, 2026
- Record last updated
- June 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Clinical trial The goal of this clinical trial is to learn how muscle weakness and atrophy develop during short periods of arm immobilization and whether a type of exercise called cross-education can help reduce these effects in women at midlife.
The main questions it aims to answer are
What changes happen in the nervous system that lead to weakness when a wrist is immobilized?
Can training the opposite arm help maintain muscle strength, muscle size, and nervous system function in the immobilized arm?
Researchers will compare women who have their wrist immobilized with or without opposite-arm resistance training.
Participants will
Wear a wrist cast on one arm for 7 days
Complete strength training with the opposite arm or no training, depending on their group
Attend study visits for strength and nervous system testing
Have non-invasive tests (like magnetic brain stimulation, muscle recordings, and muscle imaging) to measure how the nervous system and muscle responds
Being studied: Wrist immobilization; Resistance training; Resistance training rehabilitation
Conditions: Muscle Weakness
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Women between 40-65 years of age
- Baseline handgrip strength >16Kg
Exclusion Criteria
- Personal or family history of blood clots
- Current use of anticoagulant medications
- Neuromuscular or metabolic diseases (e.g., multiple sclerosis, diabetes)
- Arthritis
- Osteoporosis or osteopenia
- History of myocardial infarction within the past year
- Chronic pain ≥3/10 for ≥3 months
- Uncontrolled hypertension (≥140/90 mmHg)
- Upper extremity surgery within the past year
- Use of assistive hand or arm device within the past year
- Fall involving the upper extremities within the past year
- Upper extremity injuries preventing safe participation
- Current use of muscle relaxants, benzodiazepines, or similar drugs
- Smoking within the past 6 months
- History of drug or alcohol abuse within the past year
- Severe anxiety or claustrophobia
- Pregnancy (current or planned)
- Allergies to medical adhesives
- High risk of sarcopenia (per SARC-F)
- Contraindications to TMS or MRI
- Upper-body resistance training within the past 6 months
- Inability/unwillingness to refrain from resistance training during study
Recruiting US locations
Neuromuscular Physiology Laboratory
Manhattan, KS 66506
Site contact: Joshua Carr, PhD · 785-532-0700 · joshuacarr@ksu.edu
Study contacts (from the official record)
- Joshua Carr, Ph.D. · 785-532-0700 · joshuacarr@ksu.edu
- Julio Hernandez-Pavon, Ph.D. · juliohpavon@ksu.edu
Similar studies in Kansas
All healthy volunteers studies in Kansas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Basilea Pharmaceutica
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Newton, KS + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Evaluation of VX-581 in Healthy Participants and in Participants With Cystic Fibrosis
Vertex Pharmaceuticals Incorporated
- Location
- Overland Park, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study of RO7890597 in Healthy Adult Volunteers
Genentech, Inc.
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–65